Danisco A/S
3
12M
3
0.09
2
- Areas of investment
Summary
Danisco A/S appeared to be the Corporate Investor, which was created in 1989. The leading representative office of defined Corporate Investor is situated in the Copenhagen. The company was established in Europe in Denmark.
Among the most successful fund investment fields, there are Health Care, Food and Beverage. Among the most popular portfolio startups of the fund, we may highlight Hyglos, Redpoint Bio. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Germany.
The common things for fund are deals in the range of 10 - 50 millions dollars. This Danisco A/S works on 71 percentage points more the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2005. The top amount of exits for fund were in 2016. The fund is constantly included in less than 2 deals per year.
The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Danisco A/S, startups are often financed by Techno Venture Management, Sanders Morris Harris, Mulligan BioCapital. The meaningful sponsors for the fund in investment in the same round are TVM Capital, Signet Healthcare Partners, RK Ventures Group. In the next rounds fund is usually obtained by TVM Capital, NRW.BANK.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.09
- Investments by industry
- Biotechnology (3)
- Other Pharmaceuticals and Biotechnology (1)
- Biomass Energy (1)
- Industrial (1)
- Health Care (1) Show 4 more
- Investments by region
-
- Germany (2)
- United States (1)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Avg. valuation at time of investment
- 82M
- Group Appearance index
- 1.00
- Avg. company exit year
- 8
- Avg. multiplicator
- 4.69
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Redpoint Bio | 13 Nov 2003 | Biotechnology, Food and Beverage, Health Care | Early Stage Venture | 10M | United States, New Jersey |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.